Elisabeth Sandoval Insider Trading
Get free email notifications about insider trading for Elisabeth Sandoval.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Elisabeth Sandoval. Elisabeth Sandoval is a in Intersect ENT, Inc. ($XENT) and a CCO & EVP, Corporate Strategy in ALDER BIOPHARMACEUTICALS INC ($ALDR) and a Chief Commercial Officer in ALDER BIOPHARMACEUTICALS INC ($ALDR) and a Chief Commercial Officer in KYTHERA BIOPHARMACEUTICALS INC ($KYTH) and a Chief Commerical Officer in KYTHERA BIOPHARMACEUTICALS INC ($KYTH) and a Director in Menlo Therapeutics Inc. ($MNLO) and a Director in Satsuma Pharmaceuticals, Inc. ($STSA).
Address: 30930 RUSSELL RANCH ROAD 3RD FLOOR WESTLAKE VILLAGE 91362 CA
Companies in which Elisabeth Sandoval is an Insider
ALDER BIOPHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Elisabeth Sandoval: CCO & EVP, Corporate Strategy, Chief Commercial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 21 2018
$ALDR Market Capitalization: $1.19B
$ALDR Previous Close: $23.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Intersect ENT, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Elisabeth Sandoval:
Holdings: 0 shares
Current Value: $0
Latest Transaction: Apr 07 2021
$XENT Market Capitalization: $369.90M
$XENT Previous Close: $13.45
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
KYTHERA BIOPHARMACEUTICALS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Elisabeth Sandoval: Chief Commerical Officer, Chief Commercial Officer
Holdings: 0 shares
Latest Transaction: Oct 02 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Satsuma Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Elisabeth Sandoval: Director
Holdings: 0 shares
Latest Transaction: Jun 16 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
VYNE Therapeutics Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Elisabeth Sandoval: Director
Holdings: 0 shares
Latest Transaction: Aug 05 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Elisabeth Sandoval
Sentiment: All, ALDR, XENT, KYTH, STSA, MNLO
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 07 2021 | XENT | Intersect ENT, Inc ... | Sandoval Elisabeth | Option Exercise | A | 20.98 | 15,896 | 333,498 | 15,896 | ||
| Aug 05 2020 | MNLO | Menlo Therapeutics ... | Sandoval Elisabeth | Director | Option Exercise | A | 1.72 | 22,500 | 38,700 | 22,500 | |
| Jun 16 2020 | STSA | Satsuma Pharmaceut ... | Sandoval Elisabeth | Director | Option Exercise | A | 26.99 | 10,000 | 269,900 | 10,000 | |
| Mar 23 2020 | MNLO | Menlo Therapeutics ... | Sandoval Elisabeth | Director | Option Exercise | A | 2.67 | 45,000 | 120,150 | 45,000 | |
| Jun 27 2019 | MNLO | Menlo Therapeutics ... | Sandoval Elisabeth | Director | Option Exercise | A | 6.02 | 11,645 | 70,103 | 45,000 | |
| Mar 21 2019 | MNLO | Menlo Therapeutics ... | Sandoval Elisabeth | Director | Option Exercise | A | 8.24 | 33,355 | 274,845 | 33,355 | |
| Feb 21 2018 | ALDR | ALDER BIOPHARMACEU ... | Sandoval Elisabeth | CCO & EVP, Corporat ... | Option Exercise | A | 13.55 | 60,000 | 813,000 | 60,000 |